Download scientific diagram | Mecanismo de acción de los antibióticos betalactámicos. Tomado de: (Suárez & Gudiol, ). from publication: Determinación. Antibióticos betalactamicos. Dr. Jairo Cerrato Toxicologo clinico. Penicilinas Cefalosporinas Inhibidores de la Carbapenemicos B-lactamasa. ANTIBIOTICOS BETALACTAMICOS. OC. Osvaldo Cabrera. Updated 13 March Transcript. RESISTENCIA. USOS CLINICOS. AMOXICILINA. DE PRIMERA .
|Published (Last):||12 August 2016|
|PDF File Size:||6.88 Mb|
|ePub File Size:||8.40 Mb|
|Price:||Free* [*Free Regsitration Required]|
Sobre los desenlaces incluidos en este resumen.
Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: Nuestros hallazgos no logran establecer diferencias betalactamicoz entre ambas estrategias.
Int J Antimicrob Agents. Evaluation of roxithromycin RU versus cephradine in pneumococcal pneumonia. Are new antibiotics better than beta-lactams for antibiooticos inpatients with community-acquired pneumonia?. Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Cochrane Database Syst Rev. Clinical Microbiology and Infection.
Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia. Infect Dis Clin Practice. Sparfloxacin European Study Group. Kinasewitz G, Wood RG.
Trovafloxacin versus high-dose amoxicillin 1 g three times daily in the treatment of anyibioticos bacterial pneumonia. Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?
Beta-lactam antibiotics have been traditionally considered first-line therapy. Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia.
Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified six systematic reviews including 36 randomized trials addressing this question. Safety and efficacy of sequential i. Diferencias entre este resumen antibkoticos otras fuentes. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic.
Study report Chuard C, Regamey C. The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia. betalcatamicos
ANTIBIOTICOS BETALACTAMICOS by Osvaldo Cabrera on Prezi
Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Study report GFXB A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. La probabilidad que futura evidencia cambie las conclusiones presentadas en este resumen es baja, debido a la certeza de la evidencia.
Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia. Su principal desarrollo es la base de datos Epistemonikos www. Epub Sep Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. El resumen de los resultados es el siguiente:.
We concluded new antibiotics are not better than beta-lactam antibiotics for the treatment of non-critical inpatients with community-acquired pneumonia in relation to clinical failure or adverse effects.
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia. Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia. Chinese Journal of Antibiotics. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults.
Planta farmaceutica para antibioticos betalactamicos by Alejandra Ovalle on Prezi
Treatment for community-acquired pneumonia in immunocompetent adults is mainly empirical. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.
Clinical phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment.
There was a problem providing the content you requested
Respiratory antobioticos for the treatment of community-acquired pneumonia: Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia. Empirical atypical coverage for inpatients with community-acquired pneumonia: New antibiotics could be more effective but the evidence is not clear until now, and its use could entail greater costs, an increase in bacterial resistance and other adverse effects.
Vogel F, Lode H.